₨ NPR
Pansafe 40
Pansafe 40 Tablet, manufactured by Vega Pharma, contains Pantoprazole Sodium Sesquihydrate 40mg. This medication is a proton pump inhibitor (PPI) that works by reducing the production of stomach acid.
Key Information about Pansafe 40 Tablet
Uses
Pansafe 40 Tablet is prescribed for various conditions related to excessive stomach acid, including:
- Peptic ulcer disease
- H. pylori infection
- Gastro-oesophageal reflux disease (GERD)
- Zollinger-Ellison syndrome
- Oesophagitis
- Acid-related dyspepsia
- NSAID-associated ulceration
- Ulcers resistant to H2 receptor antagonists
- Gastrointestinal (GI) bleeding from stress
- Prophylaxis for acid aspiration syndrome during induction of anesthesia
₨8.00
Ask about productDescription
Pansafe 40 Tablet is not recommended if you are:
- Concomitantly using rilpivirine, atazanavir, or nelfinavir.
- Lactating.
Precautions
- Gastric malignancy should be ruled out before starting treatment.
- Consider zinc supplementation during IV therapy if you are prone to zinc deficiency.
- Pregnancy: Use with caution.
- Monitoring: Magnesium levels should be monitored before initiation and periodically during prolonged use.
- Lactation: It’s not known if pantoprazole is distributed into breast milk; therefore, it’s not recommended during lactation.
Interactions
Pansafe 40 may interact with other medications, potentially leading to:
- Increased risk of digoxin-induced cardiotoxic effects.
- Increased risk of hypomagnesaemia with diuretics.
- May increase INR and prothrombin time of warfarin.
- May increase serum concentration of methotrexate and saquinavir.
- Delayed absorption and decreased bioavailability with sucralfate.
- Decreased absorption of ketoconazole and itraconazole.
- Potentially Fatal: May decrease serum levels and pharmacological effects of rilpivirine, atazanavir, and nelfinavir.
Side Effects
Common side effects (1-10% occurrence) include:
- Headache (>4%)
- Abdominal pain (4%)
- Diarrhea (4%)
- Chest pain (4%)
- Pruritus (4%)
- Rash (4%)
- Vomiting (>4%)
- Constipation (<4%)
- Facial edema (<4%)
- Generalized edema (<2%)
- Flatulence (<4%)
- Hyperglycemia (1%)
- Nausea (1%)
- Photosensitivity (<2%)
Additional information
| form | PACK |
|---|
Reviews
There are no reviews yet.